About UPSA
UPSA is a French pharmaceutical laboratory founded in 1935 that has established itself as a leading manufacturer of self-medication products and medical devices. The company operates one of France's largest pharmaceutical industrial sites in Agen and exports to over 60 countries worldwide. UPSA specializes in six therapeutic areas: pain and fever, respiratory conditions, digestion, sleep disorders, vitality, and women's health.
Since 2019, UPSA has been a subsidiary of Taisho Pharmaceutical, Japan's largest self-medication company, and continues to innovate through its strategic "Conquest 2027" growth plan. The company achieved B Corp certification in 2024, recognizing its commitment to high social and environmental standards. With flagship brands like Dafalgan, Efferalgan, and Fervex, UPSA maintains its position as France's leading paracetamol producer and the global leader in effervescent pharmaceutical technology.
FAQs
- When was UPSA founded?
- UPSA was founded in 1935.
- Who is the CEO of UPSA?
- Isabelle Van Rycke is the CEO.
- What industries or markets does UPSA operate in?
- UPSA operates in the following markets: Self Medication, Medical Devices, Over the Counter (OTC) Drugs, Pain Management, Respiratory Health, Digestive Health, Women's Health, Sleep Aids, Health and Wellness, and Pharmaceutical.
- How many employees does UPSA have?
- UPSA has 1001-5000 employees.
- Where does UPSA have employees?
- UPSA has employees in France.
- Is UPSA hiring?
- Yes, UPSA has 1 open remote job.
- Does UPSA support remote work or working from home?
- Yes, UPSA is a remote-friendly company.
- Does UPSA offer a four-day work week?
- No, UPSA does not offer a four-day work week.
- What is UPSA's tech stack?
- UPSA has 2 technologies in their tech stack.
- What is UPSA's website?
- UPSA's website is upsa.com.
- Where can I find UPSA on social media?
- You can find UPSA on LinkedIn.
France
Switzerland only
